Memiş D.Hekimo?lu S.Karaçayir Y.Vatan I.Yandim T.2024-06-122024-06-1220071304-0871https://hdl.handle.net/20.500.14551/17537Lansoprazole is a substituted benzimidazole that has gained widespread use in the treatment of acidic and peptic ulcer disease. Adverse events with the drug are rare and involve mainly the gastrointestinal and central nervous systems. Skin inflammation, urticaria, pruritus, alopecia, and dry skin have been reported in 0.5-1.5 % of patients. We report a case of a 56-year-old man with peptic ulcers who developed periorbital edema, edema of the skin, generalized pruritis and urticaria, a swollen tonque, increase sweating and loss of conciousness. These findings suggest that the chemically related lansoprazole can, as a group, cause anaphylactic reactions; however, the rate is comparatively low. Since anaphylaxis is a potentially serious reaction, more precise information is needed regarding its frequency, and healthcare professionals need to be aware of this possibility when prescribing these agents.trinfo:eu-repo/semantics/closedAccessAnaphylactic Reactions; LansoprazoleAnaphylactic reaction to lansoprazoleLansoprazole karşi anaflaktik reaksiyonArticle3532092112-s2.0-34548253542N/A